Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
View More
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Spotlight
View More
Case Based Peer Perspectives
Case-Based Roundtable Series
Clinical Trials
Podcasts
Precision Medicine
Special Reports
Case Based Peer Perspectives
Case-Based Roundtable Series
Clinical Trials
Podcasts
Precision Medicine
Special Reports
NEWS
All News
Clinical Focus
Special Reports
All News
Clinical Focus
Special Reports
CONFERENCES
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
PUBLICATIONS
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
All Publications
Evolving Paradigms
Roundtable Meetings Spotlight
Targeted Therapies in Oncology
CME/CE
RESOURCES
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
Case-Based Roundtable Series
Clinical Trials
Partners
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
eNewsletter
eNewsletter
Search
Advertisement
Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Bone Marrow & SCT
BTK Inhibitors: In-Focus
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR-Positive Lung Cancer
Endometrial Cancer
Follicular Lymphoma
HCC
Lung Cancer
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Renal Cell Carcinoma
Small Cell Lung Cancer
Thyroid Cancers
Clinical Focus
See All >
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Spotlight
See All >
Case Based Peer Perspectives
Case-Based Roundtable Series
Clinical Trials
Podcasts
Precision Medicine
Special Reports
Soft Tissue Sarcoma with Jonathan C. Trent, MD, PhD and Shreyaskumar R. Patel, MD: Case 1
Soft Tissue Sarcoma with Jonathan C. Trent, MD, PhD and Shreyaskumar R. Patel, MD
EP. 1: Shreyaskumar R. Patel, MD: Leiomyosarcoma Differing From Those Arising at Other Sites
December 21st 2015
EP. 2: Shreyaskumar R. Patel, MD: Standard of Care for Invasive, Unresectable Leiomyosarcoma
December 21st 2015
EP. 3: Shreyaskumar R. Patel, MD: Risk/Benefit Ratio of Using Ifosfamide in This Patient
December 21st 2015
EP. 4: Shreyaskumar R. Patel, MD: Additional Chemotherapy in This Patient
December 21st 2015
EP. 5: Shreyaskumar R. Patel, MD: Targeted Therapies Influencing Treatment Options
December 21st 2015
EP. 6: Shreyaskumar R. Patel, MD: Additional Options Available for Durable Response
December 21st 2015
EP. 7: Jonathan C. Trent, MD, PhD: Leiomyosarcoma Differing From Those Arising at Other Sites
December 21st 2015
EP. 8: Jonathan C. Trent, MD, PhD: Standard of Care for Invasive, Unresectable Leiomyosarcoma
December 21st 2015
EP. 9: Jonathan C. Trent, MD, PhD: Risk/Benefit Ratio of Using Ifosfamide in This Patient
December 21st 2015
EP. 10: Jonathan C. Trent, MD, PhD: Additional Chemotherapy in This Patient
December 21st 2015
Next >>
Advertisement
Advertisement